Stryker completes acquisition of Amplitude Vascular Systems - MassDevice
Stryker→Amplitude Vascular Systems
May 8, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Mobia Medical has completed the acquisition of Mobia Medical, a medical devices business in Texas, for $150.0 million. Mobia Medical is a commercial-stage healthcare medical devices company focused on stroke recovery for survivors with life-altering motor impairments, supporting motor function rehabilitation. The healthcare M&A deal is structured as an initial public offering, with shares priced at $15.00 per share and expected gross proceeds of approximately $150.0 million for TX acquisitions. The other acquisition follows a Nasdaq Global Select Market listing under ticker MOBI, with trading expected to begin May 8, 2026, and closing expected May 11, 2026, subject to customary conditions. Mobia Medical acquisition activity includes a 30-day underwriters’ option to purchase up to an additional 1,500,000 shares, aligning with other acquisition financing for healthcare deals TX.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Stryker→Amplitude Vascular Systems
May 8, 2026
Odyssey Therapeutics
May 8, 2026
Odyssey Therapeutics
May 8, 2026
Angelini Pharma→Catalyst Pharmaceuticals
May 7, 2026
Stryker→Amplitude Vascular Systems
May 7, 2026